Cargando…

Comprehensive Pan-Cancer Analyses of Immunogenic Cell Death as a Biomarker in Predicting Prognosis and Therapeutic Response

SIMPLE SUMMARY: Immunogenic cell death (ICD) is an important mechanism underlying anti-cancer therapy response by activating the immune system. However, the landscape and predictive value of ICD among cancers remain to be elucidated. In this study, we carried out a comprehensive analysis integrating...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yuan, Huang, Yongbiao, Yang, Mu, Yu, Yulong, Chen, Xinyi, Ma, Li, Xiao, Lingyan, Liu, Chaofan, Liu, Bo, Yuan, Xianglin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736000/ https://www.ncbi.nlm.nih.gov/pubmed/36497433 http://dx.doi.org/10.3390/cancers14235952

Ejemplares similares

Comprehensive and Integrative Analysis of Two Novel SARS-CoV-2 Entry Associated Proteases CTSB and CTSL in Healthy Individuals and Cancer Patients
por: Huang, Yongbiao, et al.
Publicado: (2022)

Establishment of a Necroptosis Related Genes Signature to Predict Prognosis and Therapeutic Response in Colon Cancer
por: Wang, Yuan, et al.
Publicado: (2022)

Characterization of the SARS-CoV-2 co-receptor NRP1 expression profiles in healthy people and cancer patients: Implication for susceptibility to COVID-19 disease and potential therapeutic strategy
por: Huang, Yongbiao, et al.
Publicado: (2022)

Construction of a Redox-Related Prognostic Model with Predictive Value in Survival and Therapeutic Response for Patients with Lung Adenocarcinoma
por: Xiao, Lingyan, et al.
Publicado: (2022)

Comprehensive analysis of the potential cuproptosis-related biomarker LIAS that regulates prognosis and immunotherapy of pan-cancers
por: Cai, Yuan, et al.
Publicado: (2022)

Comprehensive characterisation of immunogenic cell death in melanoma revealing the association with prognosis and tumor immune microenvironment
por: Ren, Jie, et al.
Publicado: (2022)

Integrative Analysis Constructs an Extracellular Matrix-Associated Gene Signature for the Prediction of Survival and Tumor Immunity in Lung Adenocarcinoma
por: Xiao, Lingyan, et al.
Publicado: (2022)

Comprehensive analysis of immunogenic cell death associated genes expression, tumor microenvironment, and prognosis in hepatocellular carcinoma
por: Xiang, Jiankang, et al.
Publicado: (2023)

Comprehensive Pan-Cancer Analysis of GINS2 for Human Tumour Prognosis and as an Immunological Biomarker
por: Meng, Wei, et al.
Publicado: (2022)

Gelsolin: A comprehensive pan-cancer analysis of potential prognosis, diagnostic, and immune biomarkers
por: Wang, Yiyang, et al.
Publicado: (2023)

Comprehensive analysis of the immunogenic cell death-related signature for predicting prognosis and immunotherapy efficiency in patients with lung adenocarcinoma
por: Cui, Yingshu, et al.
Publicado: (2023)

Immunogenic cell death-related classifications guide prognosis and immunotherapy in osteosarcoma
por: Zong, Yuan, et al.
Publicado: (2023)

Analysis of Ferroptosis-Related LncRNAs Signatures Associated with Tumor Immune Infiltration and Experimental Validation in Clear Cell Renal Cell Carcinoma
por: Chen, Xinyi, et al.
Publicado: (2022)

Pan-cancer analyses of pyroptosis with functional implications for prognosis and immunotherapy in cancer
por: Liu, Aibin, et al.
Publicado: (2022)

Pan-cancer analysis reveals IGFL2 as a potential target for cancer prognosis and immunotherapy
por: Wang, Yuqi, et al.
Publicado: (2023)

Identification of a prognostic classifier based on EMT-related lncRNAs and the function of LINC01138 in tumor progression for lung adenocarcinoma
por: Xiao, Lingyan, et al.
Publicado: (2022)

Cilengitide, an αvβ3-integrin inhibitor, enhances the efficacy of anti-programmed cell death-1 therapy in a murine melanoma model
por: Pan, Xin, et al.
Publicado: (2022)

Pirfenidone facilitates immune infiltration and enhances the antitumor efficacy of PD-L1 blockade in mice
por: Qin, Wan, et al.
Publicado: (2020)

A Novel Prognostic Signature for Survival Prediction and Immune Implication Based on SARS-CoV-2–Related Genes in Kidney Renal Clear Cell Carcinoma
por: Huang, Yongbiao, et al.
Publicado: (2022)

A Genetic Variant in CD274 Is Associated With Prognosis in Metastatic Colorectal Cancer Patients Treated With Bevacizumab-Based Chemotherapy
por: Qin, Wan, et al.
Publicado: (2022)

Comprehensive Pan-Cancer Analyses of Pyroptosis-Related Genes to Predict Survival and Immunotherapeutic Outcome
por: Wang, Qilin, et al.
Publicado: (2022)

Immunogenic cell death-led discovery of COVID-19 biomarkers and inflammatory infiltrates
por: Zhuo, Jianzhen, et al.
Publicado: (2023)

Comprehensive Pan-Cancer Analysis of Senescence With Cancer Prognosis and Immunotherapy
por: Zhao, Qinfei, et al.
Publicado: (2022)

A pan-cancer analysis of the MAPK family gene and their association with prognosis, tumor microenvironment, and therapeutic targets
por: Qin, Yuan-Yuan, et al.
Publicado: (2023)

The application and research progress of anti-angiogenesis therapy in tumor immunotherapy
por: Tu, Jingyao, et al.
Publicado: (2023)

Biomarkers of Radiotherapy-Induced Immunogenic Cell Death
por: Vaes, Rianne D. W., et al.
Publicado: (2021)

MIR4435-2HG Is a Potential Pan-Cancer Biomarker for Diagnosis and Prognosis
por: Zhong, Chenming, et al.
Publicado: (2022)

Comprehensive pan-cancer analysis reveals NUSAP1 is a novel predictive biomarker for prognosis and immunotherapy response
por: Zheng, Hong, et al.
Publicado: (2023)

Immunogenic cell death-associated biomarkers classification predicts prognosis and immunotherapy efficacy in pancreatic ductal adenocarcinoma
por: Peng, Wenguang, et al.
Publicado: (2023)

Pan-cancer analyses identify DCBLD2 as an oncogenic, immunological, and prognostic biomarker
por: Xie, Pan, et al.
Publicado: (2022)

LAMP2 as a Biomarker Related to Prognosis and Immune Infiltration in Esophageal Cancer and Other Cancers: A Comprehensive Pan-Cancer Analysis
por: Liu, Shan-peng, et al.
Publicado: (2022)

Artificial intelligence in clinical decision support systems for oncology
por: Wang, Lu, et al.
Publicado: (2023)

Pan-cancer immunogenic death analysis identifies key roles of CXCR3 and CCL18 in hepatocellular carcinoma
por: Guo, Jia, et al.
Publicado: (2023)

Characterization of molecular subtypes based on chromatin regulators and identification of the role of NPAS2 in lung adenocarcinoma
por: Huang, Yongbiao, et al.
Publicado: (2023)

Comprehensive Pan-Cancer Analysis of KIF18A as a Marker for Prognosis and Immunity
por: Liu, Ting, et al.
Publicado: (2023)

Comprehensive pan-cancer analysis of STAT3 as a prognostic and immunological biomarker
por: He, Zhibo, et al.
Publicado: (2023)

Exploring the Prognostic Value, Immune Implication and Biological Function of H2AFY Gene in Hepatocellular Carcinoma
por: Huang, Yongbiao, et al.
Publicado: (2021)

A comprehensive analysis of PANoptosome to prognosis and immunotherapy response in pan-cancer
por: Zhuang, Lingling, et al.
Publicado: (2023)

DEF6 has potential to be a biomarker for cancer prognosis: A pan-cancer analysis
por: Yuan, Ziming, et al.
Publicado: (2023)

Characterization of SHCBP1 to prognosis and immunological landscape in pan-cancer: novel insights to biomarker and therapeutic targets
por: Jiang, Fei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rllo3b009v2jshjokj7gag9vub